ID   MDA-1386Ln
AC   CVCL_H541
SY   MDA-1386LN; MDA1386LN; MDA1386Ln; 1386LN; 1386Ln
DR   Cosmic; 2131849
DR   Cosmic; 2439757
DR   Wikidata; Q54904551
RX   PubMed=14724901;
RX   PubMed=15641986;
RX   PubMed=21868764;
RX   PubMed=28196595;
RX   PubMed=29156801;
WW   https://tcpaportal.org/mclp/
CC   Part of: MD Anderson Cell Lines Project.
CC   Omics: Deep exome analysis.
CC   Omics: Protein expression by reverse-phase protein arrays.
CC   Omics: Transcriptome analysis by microarray.
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000027.
ST   Source(s): PubMed=21868764
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11
ST   D16S539: 9,13
ST   D5S818: 12
ST   D7S820: 8,12
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 20
DI   NCIt; C4043; Hypopharyngeal squamous cell carcinoma
DI   ORDO; Orphanet_494547; Squamous cell carcinoma of the hypopharynx
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_6979 ! MDA-1386
OI   CVCL_H542 ! MDA-1386Tu
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 18
//
RX   PubMed=14724901; DOI=10.1002/hed.10344;
RA   Wreesmann V.B., Wang D., Goberdhan A., Prasad M., Ngai I.,
RA   Schnaser E.A., Sacks P.G., Singh B.;
RT   "Genetic abnormalities associated with nodal metastasis in head and
RT   neck cancer.";
RL   Head Neck 26:10-15(2004).
//
RX   PubMed=15641986; DOI=10.1111/j.1600-0714.2004.00258.x;
RA   Vigneswaran N., Wu J., Sacks P.G., Gilcrease M., Zacharias W.;
RT   "Microarray gene expression profiling of cell lines from primary and
RT   metastatic tongue squamous cell carcinoma: possible insights from
RT   emerging technology.";
RL   J. Oral Pathol. Med. 34:77-86(2005).
//
RX   PubMed=21868764; DOI=10.1158/1078-0432.CCR-11-0690;
RA   Zhao M., Sano D., Pickering C.R., Jasser S.A., Henderson Y.C.,
RA   Clayman G.L., Sturgis E.M., Ow T.J., Lotan R., Carey T.E., Sacks P.G.,
RA   Grandis J.R., Sidransky D., Heldin N.-E., Myers J.N.;
RT   "Assembly and initial characterization of a panel of 85 genomically
RT   validated cell lines from diverse head and neck tumor sites.";
RL   Clin. Cancer Res. 17:7248-7264(2011).
//
RX   PubMed=28196595; DOI=10.1016/j.ccell.2017.01.005;
RA   Li J., Zhao W., Akbani R., Liu W.-B., Ju Z.-L., Ling S.-Y., Vellano C.P.,
RA   Roebuck P., Yu Q.-H., Eterovic A.K., Byers L.A., Davies M.A., Deng W.-L.,
RA   Gopal Y.N.V., Chen G., von Euw E.M., Slamon D.J., Conklin D.,
RA   Heymach J.V., Gazdar A.F., Minna J.D., Myers J.N., Lu Y.-L., Mills G.B.,
RA   Liang H.;
RT   "Characterization of human cancer cell lines by reverse-phase protein
RT   arrays.";
RL   Cancer Cell 31:225-239(2017).
//
RX   PubMed=29156801; DOI=10.18632/oncotarget.21174;
RA   Kalu N.N., Mazumdar T., Peng S.-H., Shen L., Sambandam V., Rao X.-Y.,
RA   Xi Y.-X., Li L.-R., Qi Y., Gleber-Netto F.O., Patel A., Wang J.,
RA   Frederick M.J., Myers J.N., Pickering C.R., Johnson F.M.;
RT   "Genomic characterization of human papillomavirus-positive and
RT   -negative human squamous cell cancer cell lines.";
RL   Oncotarget 8:86369-86383(2017).
//